Wyeth
Five Giralda Farms
Madison
New Jersey
07940
United States
Tel: 973-660-5500
Fax: 973-660-7111
Website: http://www.wyeth.com/
About Wyeth
At Wyeth we have a vision of leading the way to a healthier world. We've committed ourselves to achieving this vision by making quality, integrity, and excellence the hallmarks of our business. Through recruitment, development, and motivation of the best people, we are continually growing and improving our business. We lead in innovation by linking pharmaceutical, biotechnology, and vaccine technologies.
Headquartered in Madison, New Jersey, Wyeth is one of the largest research-based pharmaceutical and health care products companies in the world. Wyeth is dedicated to solving the world's most critical health problems through research and development, spending approximately $2.1 billion in overall R&D in 2002. With annual sales of nearly $14.6 billion in 2002 and products sold in more than 140 countries, Wyeth is truly a global health care leader.
Our efforts focus on finding and developing new drugs that will enhance the quality of health care worldwide. Our discovery and development process - based on the scientific platforms of small molecules, therapeutic proteins, and vaccines - has led to innovative treatment and prevention strategies for musculoskeletal diseases, bacterial meningitis, hemophilia, and other serious threats to health worldwide.
We are committed to excellence - in the results we achieve and in how we achieve them. We pride ourselves on quality manufacturing; responsible sales, marketing, and licensing alliances; commitment to educational programs and initiatives; and service to health care professionals and patients.
We employ more than 42,000 people worldwide - each one committed to improving the health of people around the world. The diverse and talented people who work at Wyeth bring to the company a full range of talent in research, marketing, sales, and manufacturing. It is our employees who keep us on the cutting edge of innovative discoveries and superior customer service.
Lead the way to a better career at Wyeth. www.wyeth.com/careers
559 articles about Wyeth
-
Tmunity Appoints Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President
7/10/2018
Tmunity Therapeutics, Inc. today announced the appointment of Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President.
-
Entasis Names Greg Norden, Former Senior Vice President And Chief Financial Officer Of Wyeth, To Its Board Of Directors
11/29/2016
-
Pfizer to Cough Up $784.6 Million to Resolve Wyeth False Claims Lawsuit
4/28/2016
-
Aridis Pharmaceuticals Strengthens Board Of Directors With Former Wyeth (Now Pfizer President Of R&D Robert Ruffolo, Jr.
4/18/2016
-
Pfizer's Wyeth to Fork Over $784.6 Million in Medicaid Rebate Settlement
2/16/2016
-
Pfizer-Allergan Combo: Facility Numbers, the Biggest Headcount Since Wyeth and R&D Philosophy
11/16/2015
-
Accelovance Continues Oncology Leadership Growth With Addition Of Former Global VP, Oncology From Wyeth/Pfizer And Bayer
9/30/2015
-
Ex-Wyeth Head Out Of The Running For Sanofi CEO Gig
12/15/2014
-
Too Much Hype Doomed Once-Successful Wyeth CEO
8/1/2014
-
Indian Units Of Pfizer Inc. And Wyeth To Merge
11/25/2013
-
Pfizer Inc. Subsidiary, Wyeth, To Redeem 5.500% Notes Due February 1, 2014
11/14/2013
-
Second Tipper in Elan Corporation PLC, Wyeth Insider Trading Case Said to be Prominent N.J. Doctor
9/6/2013
-
Former Pfizer Inc./Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
8/6/2013
-
Pfizer Inc. Subsidiary, Wyeth, to Redeem 5.500% Notes Due March 15, 2013
11/26/2012
-
Alzheimer's Expert Leaked Inside Information on Elan Corporation PLC, Wyeth Drug
11/26/2012
-
Pfizer Inc.'s Wyeth Ordered to Face Class-Action Over Pristiq
9/19/2012
-
Pfizer Inc.'s Wyeth Unit Seeks $960 Million in Damages From Sun Pharmaceutical Industries Ltd
2/20/2012
-
Intellect Neurosciences, Inc. Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer Inc.
12/15/2011
-
Nestle SA Reportedly Eyeing Wyeth's Formula Milk Powder Business
8/8/2011
-
US High Court Rejects Wyeth Appeal In Hormone-Therapy Case
6/22/2011